NeueHealth, Inc.
NEUE
$6.73
$0.010.15%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.31% | 18.90% | 28.83% | 24.44% | 97.37% |
| Total Other Revenue | -27.25% | -22.91% | -34.78% | -26.92% | 18.00% |
| Total Revenue | -20.57% | -13.54% | -24.16% | -18.45% | 28.62% |
| Cost of Revenue | -30.19% | -19.32% | -27.52% | -24.31% | 32.05% |
| Gross Profit | 70.48% | 16.94% | -8.54% | 19.27% | 3.26% |
| SG&A Expenses | 0.13% | -32.52% | -0.07% | -15.97% | -25.34% |
| Depreciation & Amortization | -10.51% | -14.89% | -14.84% | -16.80% | -25.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.73% | -23.11% | -21.31% | -22.27% | 13.14% |
| Operating Income | 44.10% | 69.09% | -17.04% | 48.04% | 36.25% |
| Income Before Tax | 29.53% | 95.19% | -21.06% | 112.06% | 37.06% |
| Income Tax Expenses | -142.26% | 182.51% | 79.04% | -47.34% | 112.60% |
| Earnings from Continuing Operations | 32.39% | 94.57% | -23.88% | 110.55% | 25.80% |
| Earnings from Discontinued Operations | 111.31% | 78.84% | 67.61% | 91.46% | 30.60% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -102.27% | 80.35% | 96.15% | -111.48% | 2,196.21% |
| Net Income | 98.82% | 90.94% | 48.04% | 90.91% | 65.65% |
| EBIT | 44.10% | 69.09% | -17.04% | 48.04% | 36.25% |
| EBITDA | 38.69% | 73.38% | -25.56% | 52.42% | 22.73% |
| EPS Basic | 93.64% | 89.50% | 44.90% | 85.09% | 64.83% |
| Normalized Basic EPS | -114.91% | 77.36% | 59.65% | 31.71% | 419.39% |
| EPS Diluted | 93.64% | 89.50% | 44.90% | 85.09% | 64.83% |
| Normalized Diluted EPS | -114.91% | 77.36% | 59.65% | 31.71% | 419.39% |
| Average Basic Shares Outstanding | 3.42% | 3.82% | 3.65% | 2.34% | 1.27% |
| Average Diluted Shares Outstanding | 3.42% | 3.82% | 3.65% | 2.34% | 1.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |